Literature DB >> 26875639

E3 ubiquitin ligases as novel targets for inflammatory diseases.

Santosh Kumar Goru1, Anuradha Pandey1, Anil Bhanudas Gaikwad2.   

Abstract

Ubiquitination is one of the post translational modifications which decide the fate of various proteins in the cells, by either directing them towards proteasomal degradation or participation in several cell signalling pathways. Recently, the role of ubiquitination has been unravelled in pathogenesis and progression of various diseases, where inflammation is critical, like obesity, insulin resistance, atherosclerosis, angiotensin-II induced cardiac inflammation and asthma. E3 ligases are known to be instrumental in regulation of the inflammatory cascade. This review focuses on the role of different E3 ligases in the development of inflammatory diseases and thus may help us to target these E3 ligases in future drug discovery to prevent inflammation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Cardiac inflammation; E3 ubiquitin ligase; Inflammation; Metabolic disorders; Ubiquitination

Mesh:

Substances:

Year:  2016        PMID: 26875639     DOI: 10.1016/j.phrs.2016.02.006

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  18 in total

1.  The SCFFBXO3 ubiquitin E3 ligase regulates inflammation in atherosclerosis.

Authors:  Divay Chandra; James Londino; Shaun Alexander; Joseph S Bednash; Yingze Zhang; Robert M Friedlander; Grant Daskivich; Diane L Carlisle; William R Lariviere; Ana Carolina Igami Nakassa; Mark Ross; Claudette St Croix; Toru Nyunoya; Frank Sciurba; Bill Chen; Rama K Mallampalli
Journal:  J Mol Cell Cardiol       Date:  2018-11-16       Impact factor: 5.000

2.  6-O-angeloylplenolin inhibits anti-IgE-stimulated human mast cell activation via suppressing calcium influx and ERK phosphorylation.

Authors:  Yangyang Yu; Dongxu Lin; Zhenyu Liu; Ran Fang; Siman Zheng; Yongxian Cheng; Zhong Huang; Chun Wai Ng; Hang Yung Alaster Lau
Journal:  Iran J Basic Med Sci       Date:  2022-05       Impact factor: 2.532

3.  Inhibition of ubiquitin-activating enzyme protects against organ injury after intestinal ischemia-reperfusion.

Authors:  Shingo Matsuo; Andrew Chaung; Deanna Liou; Ping Wang; Weng-Lang Yang
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-05-17       Impact factor: 4.052

4.  Ubiquitylation of MFHAS1 by the ubiquitin ligase praja2 promotes M1 macrophage polarization by activating JNK and p38 pathways.

Authors:  Jing Zhong; Huihui Wang; Wankun Chen; Zhirong Sun; Jiawei Chen; Yajun Xu; Meilin Weng; Qiqing Shi; Duan Ma; Changhong Miao
Journal:  Cell Death Dis       Date:  2017-05-04       Impact factor: 8.469

5.  Structural and functional characterization of hMEX-3C Ring finger domain as an E3 ubiquitin ligase.

Authors:  Sayed Ala Moududee; Yiyang Jiang; Nshogoza Gilbert; Guodong Xie; Zheng Xu; Jihui Wu; Qingguo Gong; Yajun Tang; Yunyu Shi
Journal:  Protein Sci       Date:  2018-09       Impact factor: 6.725

Review 6.  Post-translational regulation of inflammasomes.

Authors:  Jie Yang; Zhonghua Liu; Tsan Sam Xiao
Journal:  Cell Mol Immunol       Date:  2016-06-27       Impact factor: 11.530

7.  A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants.

Authors:  Mads Gabrielsen; Lori Buetow; Mark A Nakasone; Syed Feroj Ahmed; Gary J Sibbet; Brian O Smith; Wei Zhang; Sachdev S Sidhu; Danny T Huang
Journal:  Mol Cell       Date:  2017-10-19       Impact factor: 17.970

8.  Calcium sensing receptor protects high glucose-induced energy metabolism disorder via blocking gp78-ubiquitin proteasome pathway.

Authors:  Yuehong Wang; Ping Gao; Can Wei; Hongzhu Li; Li Zhang; Yajun Zhao; Bo Wu; Ye Tian; Weihua Zhang; Lingyun Wu; Rui Wang; Changqing Xu
Journal:  Cell Death Dis       Date:  2017-05-18       Impact factor: 8.469

Review 9.  E3 Ubiquitin Ligases Neurobiological Mechanisms: Development to Degeneration.

Authors:  Arun Upadhyay; Vibhuti Joshi; Ayeman Amanullah; Ribhav Mishra; Naina Arora; Amit Prasad; Amit Mishra
Journal:  Front Mol Neurosci       Date:  2017-05-19       Impact factor: 5.639

10.  Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling.

Authors:  Hanhan Dai; Minjing Li; Wei Yang; Xiucui Sun; Peiyuan Wang; Xia Wang; Jiaqi Su; Xu Wang; Xuemei Hu; Mingdong Zhao
Journal:  Aging (Albany NY)       Date:  2020-06-12       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.